Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-24

Clinical Trial Update: Fecal Microbiota Transplantation for IBS [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating fecal microbiota transplantation for irritable bowel syndrome with diarrhea is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Madhusudan (Madhu) Grover, MBBS | Conditions: Irritable Bowel Syndrome, Diarrhea | Phase 2 | Status: RECRUITING